Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Summary of Segment Reporting

The table below summarizes the significant expense categories regularly reviewed by the CODM for the years ended December 31, 2024, and 2023:

	Year Ended December 31,
(in thousands)	2024			2023
Revenue	$	8,740		$	8,864
Gross Profit		5,676			4,983
Gross profit %		64.9	%		56.2	%
Operating expenses:
General and administrative		5,637			6,832
Sales and Marketing		6,254			8,709
Development		1,645			3,655
Clinical, Quality, Regulatory		2,650			2,747
Total Expenses		16,186			21,943
Stock Based Compensation		478			670
Other Expense		177			2,579
Net loss		(11,165	)		(20,209	)